Related Experiment Video
Updated: Jun 12, 2026

Murine Ileocolic Bowel Resection with Primary Anastomosis
Published on: October 29, 2014
Surgical interventions in inflammatory bowel disease: Indications, techniques, outcomes, and future directions
Himanshu Agrawal1, Nikhil Gupta2
1Department of Surgery, University College of Medical Sciences (University of Delhi), GTB Hospital, Delhi 110095, India.
Background:
Inflammatory bowel disease (IBD), encompassing ulcerative colitis (UC) and Crohn's disease (CD), is a chronic relapsing condition in which surgical intervention remains a cornerstone of management despite advances in medical therapy. Surgery plays a definitive role in UC and a complication-directed, bowel-preserving role in CD.
Aim:
To provide a comprehensive narrative overview of contemporary surgical management in IBD, focusing on indications, operative strategies, perioperative optimization, postoperative outcomes, and future directions.
Methods:
A narrative review was conducted following the principles of the PRISMA 2009 guidelines. A comprehensive literature search of PubMed/MEDLINE, EMBASE, Scopus, and the Cochrane Library was performed for studies published between January 2000 and December 2024. Relevant original studies, systematic reviews, and meta-analyses addressing surgical interventions in adult IBD patients were included. Evidence was synthesized descriptively.
Results:
Surgical indications in UC include medically refractory disease, dysplasia or malignancy, and life-threatening complications, with restorative proctocolectomy and ileal pouch-anal anastomosis (IPAA) representing the standard elective procedure. In CD, surgery is primarily indicated for fibrostenotic and penetrating complications, with emphasis on bowel-sparing approaches such as limited resection and strictureplasty. Minimally invasive and robotic techniques have demonstrated favorable short-term outcomes without compromising long-term results. Perioperative optimization-including nutritional support, steroid minimization, and appropriate integration of biologic therapy-plays a critical role in reducing complications. Postoperative recurrence in CD and pouch-related disorders following IPAA remain major challenges, requiring structured surveillance and multidisciplinary care.
Conclusion:
Surgery continues to play a vital and evolving role in the management of IBD. Advances in surgical techniques, perioperative care, and integration with medical therapy have improved outcomes and quality of life. Optimal results depend on individualized decision-making within a multidisciplinary framework, with ongoing research needed to refine strategies for recurrence prevention and long-term functional preservation.
Related Concept Videos
Inflammatory Bowel Disease V: Surgical Management
Here are some common surgical interventions for IBD:
Inflammatory Bowel Disease IV: Pharmacological Management
Pharmacologic...
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the colonic...
Inflammatory Bowel Disease I: Introduction
Inflammatory Bowel Disease IV: Clinical Manifestations
Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by transmural...
